Instanosis receives FDA Breakthrough Device Designation for its rapid xylazine urine test to support faster clinical detection.
BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results